~" Acute arterial embolism continues to be a major cause of stroke morbidity in children and young adults. Potential therapy modalities include medical management and/or cerebral revascularization. The canine middle cerebral artery (MCA) was embolized by means of a pliable cylinder, 8 mm long by 1.6 mm in diameter, via the internal carotid artery. Control and experimental embolectomies were performed 6 hours following embolization. The experimental animals were treated with either dimethyl sulfoxide (DMSO) or methyl prednisolone. In the control animals, the average area of infarction in the brain was 1.45 cu cm. The animals treated with methyl prednisolone (2 mg/kg) or DMSO (2 gm/kg) showed no infarction of the brain, whereas methyl prednisolone (30 mg/kg) did not prevent infarction.
PIDEMIOLOGICAL survey of cerebrovascular disease indicates that thromboembolic infarction is a major cause of cerebrovascular accident. The morbidity is high and the cost of care for victims is staggering) ~ The heart and extracranial carotid artery are the two major sources of cerebral emboli, most of which lodge in the middle cerebral artery (MCA). The medical treatment has been largely preventive and supportive.
A variety of drugs including steroids, dextran, barbiturates, and anticoagulants are used in the management of cerebral ischemia, despite controversy over their benefits in clinical and experimental situations. 5,8,11 '7,37,4~ The operative treatment includes microsurgical embolectomy and cerebral revascularization. 1~ ' 64 Our experimental studies on dogs have shown that embolectomy of the MCA performed between 2 and 5 hours postembolism could prevent cerebral infarction. Embolectomy beyond 5-hour periods invariably resulted in severe hemorrhagic infarction with concomitant neurological impairment. TM It is seldom possible, however, to perform MCA embolectomy in humans within such a short period of time; few cases are reported in which embolectomy was done within 24 hours of embolism, with variable results (Table 1) . For practical purposes, therefore, the period within which a safe microsurgical embolectomy can be performed needs to be extended.
The salutary biological properties of dimethyl sulfoxide (DMSO) and the controversial role of steroids in cerebral ischemia have been noted in previous reports? , 17 ,es In the present study, effects of DMSO and methyl prednisolone were evaluated in dogs subjected to embolization followed by MCA embolectomy.
Materials and Methods
Twenty-seven mongrel dogs weighing between 15 and 22 kg were selected and divided into two groups: a control group of nine animals, and an experimental group of 18 animals. The embolus material was mixed from Microfil orange polymer (50% Microfil and 50% diluent*) 24 hours before use. The embolus material was introduced into a glycerin-lubricated tube of PE 240, to make a cylinder 1.6 mm in diameter.
All animals in the study underwent the following procedures. The animals were anesthetized by intravenous sodium pentobarbital (25 mg/kg) and then intubated. Controlled respiration was maintained by a Harvard respirator.t Blood gases were checked frequently to maintain the pH, pO~, and pCO2 within physiological limits. bleeding indicated it was lodged intracranially beyond the internal carotidmaxillary artery junction. The EEG, EKG, and BP were continually monitored before and immediately after embolus injection. Since the embolus is radiopaque, its position was checked with lateral and anteropostefior skull films. The cannula was then withdrawn from the ICA and the needle hole repaired with two or three 6-0 polypropylene stitches.* The neck incision was then closed in layers.
In both the control and experimental animals, MCA embolization was followed 6 hours later by embolectomy. The experimental group, however, also received DMSO or methyl prednisolone. This group was divided into three subgroups: 1) Six animals received 2 gm/kg DMSO diluted in 250 cc of Ringer's lactate solution intravenously for 2 hours; the infusion was started immediately following MCA embolization. 2) Six animals were given 30 mg/kg methyl prednisolone (SoluMedrol) intravenously as in subgroup 1. 3) Six animals were treated with 2 mg/kg methyl prednisolone intravenously as in the previous group. The dose of steroid was repeated on the first and second days after embolectomy.
A temporal craniectomy was performed and the MCA was exposed by microsurgical technique. The location and state of the embolus was noted in the MCA, and then it was removed by a 0.5 mm arteriotomy over the distal portion of the embolus by a small, manually adjusted suction cannula# developed in our laboratory. TM The arteriotomy site was closed with 10-0 nylon sutures,:~ and the rest of the incision closed in layers. Animals in which the embolus was fragmented or lodged distal to the bifurcation of the MCA were discarded from the study. The neurological examinations for all animals were recorded on a neurological check sheet for 21 days after embolectomy.
Animals that survived for 3 weeks postoperatively were anesthetized and underwent a left carotid angiogram. All the animals included in the study had patent MCA's. *6-0 Prolene, CI taper, manufactured by Ethicon, Inc., Somerville, New Jersey. tSuction cannula manufactured by Codman and Shurtleff, Randolph, Massachusetts.
~:10-0 Ethilon, 28506, manufactured by Ethicon, Inc., Somerville, New Jersey. Animals were hemodiluted with normal saline via cannulas in both carotid arteries and jugular veins, followed by infusion of 10% formalin. The brain was removed and studied grossly, weighed, and immersed in 10% formalin. When animals died before sacrifice, the MCA was inspected macroscopically at autopsy for possible stenosis or thrombosis. The excised segment of the MCA was later subjected to histopathological examination. The brain was serially sectioned coronally, and photographic enlargements of both sides of each coronal section made at • 7 magnification. A planimeter was used to compute the infarct areas on each side of the coronal sections. The infarct volume in each section was determined by adding the two infarcted areas from each side, dividing by two, and multiplying this average area by the thickness of the coronal slices (which were generally 0.8 mm thick). The coronal slice infarction volumes were added to obtain the total infarction volume for a given brain.
As a basis for comparing the groups, a statistical analysis ~' of the volume of infarction was done by the Kruskal-Wallis H test; the Dunn procedure was used for pair-wise comparison of the groups.
Results
Three of the nine control animals embolectomized 6 hours following embolization died within 48 hours. In the postoperative period these three animals were extremely ill, with impaired consciousness and contralateral hemiplegia. Autopsy revealed massive hemorrhagic infarction of the ipsilateral cerebral hemisphere in each of the animals ( Fig. 1 upper left) . The MCA was patent in these three animals. Six control animals survived for 21 days. Three were hemiplegic with diminished consciousness, and intermittent intravenous fluid had to be administered for nourishment. Large infarctions of the thalamus, internal capsule, piriform, and ectosylvian lobe were observed in these animals at autopsy. The other three control animals also had persistent hemiparesis, although their level of consciousness improved 24 to 48 hours postoperatively. Areas of hemorrhagic infarction in the piriform lobe and amygdala were noted at autopsy in these animals. The average volume of infarction in the control group was 1.45 cu cm ( Table 2) .
The experimental animals treated with DMSO were observed to be normal, with no impairment of consciousness or neurological deficit. Coronal sections of the brain also were normal in these animals ( Fig. 1 upper  right) . The six animals treated with the large dosage of methyl prednisolone developed significant hypotension, remained comatose, and died within 24 to 72 hours of embolectomy. The systolic blood pressure dropped from 160 to 140 mm Hg down to 50 mm Hg (four animals) and 65 mm Hg (two animals) for a period of 30 to 65 minutes. Autopsy revealed massive hemorrhagic infarction of the ipsilateral hemisphere in all six animals ( Fig. 1 lower left) . The average volume of infarction in this subgroup was 2.31 cu cm ( Table 2 ). The animals treated with the low dosage of methyl prednisolone, on the other hand, had no neurological deficit, and no pathological lesion was seen at autopsy ( Fig.  1 lower right) . In 18 animals (six control, six low-dose methyl prednisolone, and six DMSO) postoperative angiogram was performed before sacrifice. The contrast filled the MCA. In these animals, as well as animals that died before planned sacrifice, the arteriotomy site was examined grossly and microscopically at autopsy. The vessels were noted to be patent without any evidence of stenosis. Statistical analysis of the control and experimental groups showed significant difference at the 0.01 level (H = 23.55, dt = 3). There was no significant difference between the control group and the high-dose methyl prednisolone subgroup (Z = + 1.46). Similarly, there was no significant difference between the low-dose methyl prednisolone subgroup and the DMSO subgroup (Z = 0). All other pair-wise comparisons among the experimental subgroups were statistically at the 0.01 level.
Discussion
Different techniques have been used in animals to produce experimental focal cerebral ischemia (Table 3) . Commonly, the MCA is occluded by a clip? 5 The drawback of such a technique is that clip occlusion may induce thrombosis of the vessel due to endothelial changes, and restoration of flow may be impaired or impossible after removal of the clip. ~9 Recently, electron microscopic studies by Dodson, et al. , TM have revealed impairment of neurogenic innervation of the cerebral vessels distal to the trunk of the clipped vessel, along with pronounced changes in the vessel wall. The pathological changes observed were related to the time of vessel occlusion. The embolization technique, on the other hand, closely simulates an embolic episode in humans and, in our experience, has been reliable and effective. We also observed that there was no endothelial damage of the MCA, even when the embolus was left in situ for 21 days.
We reported earlier that microsurgical canine MCA embolectomy performed within 5 hours of embolization did not produce neurological impairment or histopathological changes in the brain; however, restoration of blood flow at 6 hours after embolectomy and beyond consistently resulted in edema and hemorrhagic infarction of the ipsilateral cerebral hemisphere. TM Sundt, et al. 53 noted that restoration of blood flow after MCA occlusion for 6 hours in squirrel monkeys resulted in increased edema and hemorrhagic infarction of the brain. dog, rhesus MCA Molinari 42 monkey *ACA = anterior cerebral artery; ICA = internal carotid artery; MCA = middle cerebral artery.
potential effect of DMSO in acute experimental head and spinal cord injuries. An impressive reduction in mortality and morbidity was found in animals treated with this compound, in contrast to those treated with more conventional medications or those used in control groups. It is apparent from our results that DMSO successfully extended the "critical period" of experimental embolectomy. Although its mode of action in cerebral ischemia can only be conjectured, DMSO has been shown to reduce oxygen consumption 3,57 and increase cellular resistance to anoxia in experimental cardiac ischemia? ~ Also, it acts as a diuretic, prevents edema, and diminishes intracranial pressure? ~ de la Torre and Surgeon ~6 noted lack of hemispheric swelling and minimal tissue necrosis in squirrel monkeys treated with DMSO after experimental MCA occlusion for 17 hours. An antiplatelet aggregative action of DMSO has been suggested and may play a significant role in the prevention of microcirculatory obstruction and "noreflow phenomenon" following focal ischemia. 13, 8a Extrusion of neuronal lysosome contents into the neuropil has been noted in squirrel monkeys by Little, et al., 32 '~a after prolonged severe cerebral ischemia. These lysosomal bodies have been referred to as "suicide bags," as release of lysosomal enzymes causes autolysis of cells. 15 Weissmann, et al.fl x showed that DMSO stabilized the lysosomal membrane, thereby preventing the release of the contained enzymes. Steroids are also known to stabilize the lysosomal membranes and prevent release of hydrolytic enzymes in hepatic, renal, and myocardial ischemia. 7,5~ Since one of the modes of action of DMSO has been found to be stimulation of adrenocorticotropic hormone (ACTH) and glucocorticoid secretion, it may be postulated that the effect of DMSO on the membrane may be via ACTH-adrenal axis. ~ The various modes of action of DMSO are shown in Table 4 .
TABLE 4
Modes of action of dimethyl sulfoxide (DMSO) and methyl prednisolone
In our experiments, significantly different results were noted between animals given high and low doses of methyl prednisolone. The animals treated with a high dosage became hypotensive during administration of the drug. Lozman, et al., 3s while evaluating the effect of a single high-dose administration of methyl prednisolone (30 mg/kg) in critically ill patients, noted that three out of four patients developed abrupt drop in BP within 4 minutes of injection. The hypotension lasted for about 30 minutes. Similarly, Thomas and Brockman 54 noted an abrupt fall in cardiac output and BP in dog s after administration of methyl prednisolone or hydrocortisone. In some animals these values returned to the levels that existed before injection of the steroid; in others, persistent circulatory depression resulted in death of the animals.
Waltz 6~ demonstrated in cats with MCA occlusion that induced hypotension was associated with diminished cortical blood flow. Also, induced hypotension caused impaired autoregulation and irreversible ischemic changes in the cortical microvasculature in some of the animals. The hypotension observed in our animals receiving 30 mg/kg methyl prednisolone may have augmented irreversible ischemic changes in the brain with resulting severe infarction.
There is considerable controversy regarding the effect of steroids in acute stroke. Donley and Sundt 17 studied the effect of large doses of dexamethasone on edema of cerebral ischemia-infarction in squirrel monkeys after temporary occlusion of the MCA. There was no difference in morbidity, mortality, histological appearance, or amount of edema associated with the ischemic lesion, between the treated and the control groups. Bartko, et al., 4 found that, compared to the control group, cats treated with dexamethasone before MCA occlusion showed diminished accumulation of fluid in the ischemic and borderline zone 2 hours after the occlusion.
Conflicting effects of steroids in acute stroke have also been reported in clinical trials. A favorable response was noted by Russek, et al., 4~ and Patten, et al., 44 while others have found disappointing results. 5, 8, 39 However, methyl prednisolone has been effective in relieving cardiac, renal, and hepatic ischemia, 7 apparently by reversing potassium loss, reducing lactic acid level, and improving oxygenation of ischemic cells? 1 Methyl pred-nisolone has been shown to increase 2.3 diphosphoglyceric acid (DPG) of the erythrocytes. 2e'46 The concentration of this organic phosphate plays a significant role in the oxygen-hemoglobin dissociation curve. Methyl prednisolone produces a right shift in the curve with increased tissue perfusion? 8 Also, 2.3 DPG has been shown to inhibit platelet aggregation when large quantities of adenosine diphosphate (ADP) and 2.3 DPG are released from erythrocytes, which may play a role in microcirculatory obstruction. Recently, in the evolution of cerebral edema induced by cold lesion in rats, Mitamura, et aL, 41 postulated a free radical mechanism for the production of cerebral edema. The edema was substantially decreased by pretreatment with methyl prednisolone, which shows strong antioxidant activity and high lipid solubility.
The present experimental data suggest that early administration of low doses of methyl prednisolone or DMSO protects the cerebral tissue from the injurious effect of ischemia and postischemic reperfusion. Such results would make these compounds particularly valuable when surgical treatment of acute cerebral embolism is contemplated.
